Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Sara Engstrand
A Phase 2, Double-Blind, Placebo-Controlled, Randomized Study of Fresolimumab in Patients With Steroid-Resistant Primary Focal Segmental Glomerulosclerosis
Kidney International Reports
Nephrology
Related publications
Rituximab Treatment of Adult Patients With Steroid-Resistant Focal Segmental Glomerulosclerosis
Clinical Journal of the American Society of Nephrology
Epidemiology
Nephrology
Critical Care
Transplantation
Intensive Care Medicine
Etanercept in Alzheimer Disease: A Randomized, Placebo-Controlled, Double-Blind, Phase 2 Trial
Neurology
Neurology
1002 Pulse Cyclophosphamide Therapy for Steroid-Resistant Focal Segmental Glomerulosclerosis in Children
Pediatric Research
Child Health
Pediatrics
Perinatology
Efficacy and Safety of Sparsentan Compared With Irbesartan in Patients With Primary Focal Segmental Glomerulosclerosis: Randomized, Controlled Trial Design (DUET)
Kidney International Reports
Nephrology
Therapeutic Effect of Oral CF101 in Patients With Rheumatoid Arthritis: A Randomized, Double-Blind, Placebo-Controlled Phase II Study
Immunome Research
A Randomized, Double-Blind, Placebo-Controlled Phase III Trial of Duloxetine in Japanese Fibromyalgia Patients
Arthritis Research and Therapy
Rheumatology
Allergy
Immunology
A Phase II, Randomized, Double-Blind, Placebo-Controlled Multicenter Trial of Endostar in Patients With Metastatic Melanoma
Molecular Therapy
Molecular Medicine
Molecular Biology
Pharmacology
Medicine
Genetics
Drug Discovery
Olaparib Combined With Abiraterone in Patients With Metastatic Castration-Resistant Prostate Cancer: A Randomised, Double-Blind, Placebo-Controlled, Phase 2 Trial
The Lancet Oncology
Oncology
Adjunctive Everolimus Therapy for Treatment-Resistant Focal-Onset Seizures Associated With Tuberous Sclerosis: A Phase 3, Randomised, Double-Blind, Placebo-Controlled Study
Turk Noroloji Dergisi
Neurology
